Eisai
0
Eisai reports data on subcutaneous lecanemab initiation
0

Eisai reports data on subcutaneous lecanemab initiation

Data presented at AAIC 2026 support further evaluation of a once-weekly 500 mg autoinjector regimen as an alternative to intravenous ...

admin admin August 3, 2026
READ MORE +
Som2ny Network
Logo
Register New Account
Compare items
  • Total (0)
Compare
0
Shopping cart